Pharmacyte BiotechPMCB
13F holders, Q2 2024 (June 30)28holders −1
3new positions
3sold out
1famous investor
$1.96avg. 13F price*
At the end of Q2 2024, 28 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings, down 1 from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were K2 Principal Fund, L.P. ($642K), Vanguard Group Inc. ($377K) and Geode Capital Management, LLC ($346K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $55K |
| Exits | 3 | $21K |
All 13F filers, Q1 2024 → Q2 2024: 97,208 shares bought and 43,061 shares sold, net +54,147 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| K2 Principal Fund, L.P. | 0.34% | No change | 327,503 | $642K |
| Vanguard Group Inc. | 0.00% | Add +10.2% | 192,387 | $377K |
| Geode Capital Management, LLC | 0.00% | Reduce -11.8% | 176,605 | $346K |
| Equitec Proprietary Markets, LLC | 1.24% | No change | 82,727 | $162K |
| Susquehanna International Group, LLP | 0.00% | Add +33.1% | 54,834 | $107K |
| Renaissance Technologies | 0.00% | Add +10.7% | 48,500 | $95K |
| Two Sigma Securities, LLC | 0.00% | New | 27,750 | $54K |
| UBS Group AG | 0.00% | Add +306288.9% | 27,575 | $54K |
| Dimensional Fund Advisors LP | 0.00% | Add +4.2% | 25,596 | $50K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +0.8% | 23,700 | $46K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 19,208 | $38K |
| BlackRock Inc. | 0.00% | Reduce -36.8% | 13,346 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +128.7% | 7,384 | $14K |
| Acadian Asset Management LLC | 0.00% | Reduce -20.6% | 2,851 | $5K |
| Aspire Private Capital, LLC | 0.00% | No change | 800 | $2K |
| Osaic Holdings, Inc. | 0.00% | Reduce -71.0% | 513 | $1K |
| Kelly Financial Services LLC | 0.00% | No change | 234 | $459 |
| Bank of America Corp. | 0.00% | Add +181.5% | 152 | $298 |
| Planning Capital Management Corp | 0.00% | New | 100 | $196 |
| Redwood Wealth Management Group, LLC | 0.00% | New | 69 | $135 |
| JPMorgan Chase & Co. | 0.00% | Add +5.6% | 19 | $37 |
| Sachetta, LLC | 0.00% | No change | 14 | $28 |
| Bfsg, LLC | 0.00% | Reduce -28.6% | 5 | $10 |
| Morgan Stanley | 0.00% | No change | 3 | $7 |
| NewEdge Advisors, LLC | 0.00% | Reduce -33.3% | 2 | $4 |
| Royal Bank of Canada | 0.00% | Add +67.3% | 261 | $0 |
| Cwm, LLC | 0.00% | Reduce -99.9% | 1 | $0 |
| Covestor Ltd | 0.00% | No change | 226 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.